Skip to main content

Advertisement

Log in

The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Clomethiazole is widely used in European countries to treat alcohol withdrawal symptoms including delirium tremens. The current study aimed to explore the effects of clomethiazole on the sleep of healthy volunteers. We postulated both a hypnotic and a REM suppressive effect as well as the occurrence of a rebound phenomenon following three days of treatment with clomethiazole. The study group was composed of five men and five women. The probands were examined in the sleep laboratory throughout a course of seven nights. The first night was considered as the adaptation night and the second as the baseline night. Prior to nights 3 to 5, probands took 384 mg clomethiazole at 22 hours. The 6th and 7th nights served to record potential effects of medication discontinuation.

The current study confirms the indication in the scientific literature with regard to hypnotic and REM–suppressive effects of clomethiazole, as well as a rebound phenomenon following discontinuation of the medication. The effect of clomethiazole on the sleep EEG was most obvious in the first half of the night. The analysis of the polysomnogram in terms of each half of the night gave no indication of a rebound phenomenon during the second half.

The REM sleep–suppressing component of clomethiazole is of great interest in connection with its use in treating delirium tremens. The rebound phenomenon in healthy controls after only three days of medication at a relatively low dosage of clomethiazole underscores the need to administer it in doses individually tailored to the extent of the alcohol withdrawal syndrome in the individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aguayo LG, Peoples RW, Yeh HH, Yevemes GE (2002) GABA (A) receptors as molecular sites of ethanol action. Director indirect actions. Curr Top Med Chem 8:869–885

    Article  Google Scholar 

  2. Bayer AJ, Bayer EM, Pathy MS, Stoker MJ (1986) A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly. Acta Psychiatr Scand 329(Suppl):104–111

    Google Scholar 

  3. Braunwarth WD (1990) Indikationen für den Einsatz von Clomethiazol. Fortschr. Med 108:504–506/10:9104

    PubMed  Google Scholar 

  4. Brower KJ, Aldrich MS, Hall JM (1998) Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcoholism: Clin Exp Res Vol 22:1864–1871

    Google Scholar 

  5. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1988) The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research 28:193–213

  6. Clark CP, Gillin JC, Goshan S, et al. (1988) Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression. Biol Psychiatry 43:601–607

    Article  Google Scholar 

  7. Dehlin O (1986) Hypnotic effect of chlormethiazole in geriatric patients during long-term treatment. Acta Psychiatr Scand 329 (Suppl):112–115

    Google Scholar 

  8. Drummond SPA, Gillin JC, Smith TL, Demodena A (1998) The sleep of abstinent pure primary alcoholic patients: Natural course and relationship to relapse. Alcohol Clin Exp Res 22:1796–1802

    PubMed  Google Scholar 

  9. Evans JL, Lewis SA, Tinker M (1972) Chlormethiazole, sleep and drug withdrawal. Psychol Med 2:239–247

    PubMed  Google Scholar 

  10. Foster JH, Peters TJ (1999) Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome. Alcohol Clin Exp Res 23:1044–1051

    PubMed  Google Scholar 

  11. Gann H, Kiemen A, Klein T, Ebert D, Backhaus J, Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1997) Schlaf und cholinerger REM-Schlaf-Induktionstest bei Patienten mit primärer Alkoholabhängigkeit. Somnologie 1:119–125

    Google Scholar 

  12. Gann H, Faulmann A, Kiemen A, Klein T, Ebert D, Backhaus J, Hornyak M, Voderholzer U, Hohagen F, Berger M, Riemann D (1998) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Sleep Research Online 1:92–95

    PubMed  Google Scholar 

  13. Gann H, Gardziella S, Backhaus J, Hohagen F, Riemann D (1999) Der Schlaf und seine cholinerge Beeinflußbarkeit bei Patienten mit primärer Alkoholabhängigkeit im subakuten Entzug. Sucht 45:89–99

    Google Scholar 

  14. Gann H, Feige B, Hohagen F, van Calker D, Geiss D, Riemann D (2001) Sleep and the cholinergic REM sleep induction test in patients with primary alcoholism. Biol Psychiatry 50:383–390

    Article  PubMed  Google Scholar 

  15. Gann H, Feige B, Fasihi S, van Calker D, Voderholzer U, Riemann D (2002) Periodic limb movements during sleep in alcohol dependent patients. Eur Arch Psychiatry Clin Neurosci 252:124–129

    Article  PubMed  Google Scholar 

  16. Gann H, Feige B, Cloot O, Wasen van H, Zinzgraf D, Hohagen F, Riemann D (2004) Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients – a double- blind- and randomized study. Pharmacopsychiatry 37(5):228–235

    Article  PubMed  Google Scholar 

  17. Gann H, Feige B, Brück R, Litsch S (2005) Hohagen F, Riemann D The effect of alcohol on polysomnographically recorded sleep in healthy subjects (in preparation)

  18. Gillin JC, Smith TL, Irwin M, et al. (1994) Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in non-depressed patients with primary alcoholism at 3- month follow up. Arch Gen Psychiatry 51:189–197

    PubMed  Google Scholar 

  19. Görtelmeyer R (1981) Schlaffragebogen SF-A und SF-B. In: Collegium Internationale Psychiatriae Scolarum (CIPS). Herausgeber. Internationale Skalen für Psychiatrie. Beltz, Weinheim, pp 357

  20. Grace J (1999) Chlormethiazole, apnoea and Alheimer’s disease. Acta Psychiatr Scand 100(3):248

    PubMed  Google Scholar 

  21. Gregg E, Akther I (1979) Chlormethiazole Abuse. Brit J Psychiatry 134:627–629

    Google Scholar 

  22. Grenn AR (1998) Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy. Pharmacol Ther 80:123–147

    Article  PubMed  Google Scholar 

  23. Hautzinger M, Bader M, Worall H, Keller F (1995) Beck-Depressions- Inventar. Hans Huber, Bern

  24. Kaldune A, Strnad J, Cornu C, Bahro M (1999) Apnea syndrome in a patient with Alzheimer dementia under chlormethiazole treatment: a clinical experience report. Acta Psychiatr Scand 99 (1):79–81

    PubMed  Google Scholar 

  25. Laux L, Glanzmann P, Schaffner P, Spielberger CD (1981) State- Trait-Angstinventar (STAI) Weinheim Beltz Testgemeinschaft

  26. Liljenberg B, Almqvist M, Broman JE, Hetta J, Roos BE (1986) The effects of chlormethiazole in EEG recorded sleep in normal elderly volunteers. Acta Psychiatr Scand 329(Suppl):34–39

    Google Scholar 

  27. Majumdar SK (1990) Chlormethiazole: Current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alc Dep 27:201–207

    Google Scholar 

  28. Morgan MY (1995) The management of alcohol withdrawal using chlormethiazole. Alcohol Alcohol 30:771–774

    PubMed  Google Scholar 

  29. Nelson, RM, Green AR, Hainsworth AH (2002) Electrophysiological actions of gamma-aminobutyric acid and chlormethiazole on recombinant GABAA receptors. Eur J Pharmacol 452:255–262

    Article  PubMed  Google Scholar 

  30. Overstall PW, Oldman PN (1987) A comparative study of lormetazepam and chlormethiazole in elderly in-patients. Age Ageing 16:45–51

    PubMed  Google Scholar 

  31. Pace-Schott EF and Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3:591–605

    PubMed  Google Scholar 

  32. Pathy MS, Bayer AJ, Stoker MJ (1986) A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. Acta Psychiatr Scand 329(Suppl):99–103

    Google Scholar 

  33. Reilly TM (1976) Physiological dependence on and symptoms of withdrawal from chlormethiazole. Brit J Psychiatry 128:375–378

    Google Scholar 

  34. Riemann D, Backhaus J (1996) Behandlung von Schlafstörungen – ein psychologisches Gruppenprogramm. Beltz, Weinheim

  35. Roehrs T, Papineau K, Rosenthal L, Roth T (1999) Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacol 20:279–86

    Article  Google Scholar 

  36. Stuppaeck C, Barnas C, Falk M, Guenther V, Hummer M, Oberbauer H, Pycha R, Withworth A, Fleichhaker W (1995) Eine modifizierte und ins Deutsche übersetzte Form der Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-A). Wien Ztschr Suchtforsch 18:39–48

    Google Scholar 

  37. Usala M, Thompson A, Whiting PJ, Wafford KA (2003) Activity of chlormethiazole at human recombinant GABAA and NMDA receptors. Br J Pharmacol 140:1045–1050

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Gann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gann, ., Hartig, K., Feige, B. et al. The effects of clomethiazole on polysomnographically recorded sleep in healthy subjects. Eur Arch Psychiatry Clin Neurosci 255, 284–290 (2005). https://doi.org/10.1007/s00406-005-0589-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-005-0589-3

Key words

Navigation